Pharma-nutrition tie-ups race to capture $150B GLP-1 companion market
As Wegovy and Mounjaro enter India and semaglutide generics loom, global pharma is partnering with Nestle, Abbott and Danone on GLP-1 companion protein and micronutrient products. Indian nutraceutical and food brands are expected to follow, opening a new white-space category projected at $150B by early 2030s.
What happened
GLP-1 nutrition category · Pharma firms are partnering with nutrition players to build GLP-1 companion products (protein shakes, fortified meals). With Mounjaro
Key facts
- $150 billion by early 2030s
Why this matters
Scout pharma partnership or licensing deals with Indian nutraceutical players to stake a claim in the GLP-1 companion white space before generics arrive.
Also reported by
- Moneycontrol · Results — 1h after first sighting